🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are urged to contact these accounts directly for source information, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share comparison photos, injection guides and claims of next-day UK delivery. Sellers promote the substance there before redirecting customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of uncertain source.

Several experts said the popularity for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and customer laws, risking penalties, legal action or imprisonment.

Platform Reaction and Content Removal

According to the social media company, the service has removed problematic material and prohibited related keywords and query recommendations. The company said it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, filled with photos of weight loss, glowing reviews and step-by-step guides for preparing or injecting at residence.

Within minutes of joining one group, a seller posted contact information, where most purchases occur. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Information and Costs

Within these communities, posts show dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20 milligrams. When asked how long a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Although the research behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to possibly serious medical dangers”.